Curia


Albany, NY
US

Contact WebSite

Curia is a global CDMO with over 30 years of experience successfully guiding clients through the complexities of drug discovery, development, and manufacturing.

We offer services across Small Molecules, Generic APIs, and Biologics backed by deep scientific expertise and a robust global network of resources and capabilities. Our dedicated teams, combined with advanced technologies, enable us to be both flexible and scalable, accelerating the delivery of your product to patients.

Article

Curia Announces Expansions to Global Network of Sterile Fill-Finish Sites
27.05.2025 • NewsPharma

Curia Announces Expansions to Global Network of Sterile Fill-Finish Sites

Curia, a CDMO, recently shared expansion plans for facilities in Glasgow, UK, and Albuquerque, NM, US.

Curia Begins Work on New Mexico Expansion
02.11.2022 • News

Curia Begins Work on New Mexico Expansion

US CDMO Curia has begun construction on an expansion of its campus in Albuquerque, New Mexico. The facility designed by Burns & McDonnell will be built by BE&K Building Group.

Curia and Replicate Bioscience Link on sRNA
15.06.2022 • News

Curia and Replicate Bioscience Link on sRNA

Research-oriented CDMO Curia, formerly known as AMRI, has agreed to cooperate with Replicate Bioscience, a company searching for ways to prevent drug resistance in cancer and to treat autoimmune and inflammatory disorders and other diseases using self-replicating RNA (srRNA).

Curia Announces Name Change for new Subsidiaries
18.02.2022 • News

Curia Announces Name Change for new Subsidiaries

US-based CDMO Curia, formerly known as AMRI, has announced that Integrity Bio and LakePharma, companies, both acquired by the company in 2021, have changed their names to Curia to reflect corporate branding.

Curia to Expand US Commercial Capability
23.08.2021 • News

Curia to Expand US Commercial Capability

Curia, the US CDMO formerly known as AMRI, has announced it will invest $35 million to expand commercial manufacturing capacity at its Rensselaer, New York, production facility over the next 18 months.

Curia Buys LakePharma
03.08.2021 • News

Curia Buys LakePharma

US CDMO Curia, formerly AMRI, has agreed to acquire LakePharma, a privately held biologics drug discovery, clinical research, development and manufacturing organization. Financial terms of the agreement have not been disclosed.

AMRI Becomes Curia, Makes Acquisition
14.07.2021 • News

AMRI Becomes Curia, Makes Acquisition

Only a day after announcing it was changing its name to Curia, the US CDMO known up to now as AMRI announced a “definitive agreement” to acquire Integrity Bio, a privately held biologics formulation and fill & finish organization headquartered in Camarillo, California.